Found 2 results
Filters: Author is B.D.B. Souza  [Clear All Filters]
L. O. Cavalcante, Melo, M. R., Dinis, V. G., Castro, R. B., Souza, B. D. B., and Longui, C. A., Quantitation of glucocorticoid receptor alpha and NF-κB pathway mRNA and its correlation with disease activity in rheumatoid arthritis patients, vol. 9, pp. 2300-2310, 2010.
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002). Guidelines for the management of rheumatoid arthritis. Arthitis Rheum. 46: 328-346. PMid:11840435   Asahara H, Fujisawa K, Kobata T, Hasunuma T, et al. (1997). Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. Arthritis Rheum. 40: 912-918. PMid:9153554   Baeuerle PA and Baltimore D (1996). NF-kappa B: ten years after. Cell 87: 13-20.   Baldwin AS Jr (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14: 649-683. PMid:8717528   Bértolo MB, Brenol CV, Schainberg CG, Neubarth F, et al. (2007). Atualização do consenso brasileiro no diagnóstico e tratamento da artrite reumatóide. Rev. Bras. Reumatol. 47: 151-159.   Boss B and Neeck G (2000). Correlation of IL-6 with the classical humoral disease activity parameters ESR and CRP and with serum cortisol, reflecting the activity of the HPA axis in active rheumatoid arthritis. Z. Rheumatol. (Suppl 2) 59: II-62-II-64.   Brenol CV, Monticielo OA, Xavier RM and Brenol JCT (2007). Artrite reumatóide e aterosclerose. Rev. Assoc. Med. Bras. 53: 465-470. PMid:17952359   Callahan LF, Pincus T, Huston JW III, Brooks RH, et al. (1997). Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years. Arthritis Care Res. 10: 381-394. PMid:9481230   Carlsson AM (1983). Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 16: 87-101.   Cobra JF, Melo MR, Faria CD, Longui CA, et al. (2009). Simultaneous evaluation of in vivo glucocorticoid sensitivity and expression of glucocorticoid receptor alpha-isoform in rheumatoid arthritis patients. Arq. Bras. Endocrinol. Metabol. 53: 24-30. PMid:19347182   Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, et al. (1997). Circadian relationships between interleukin (IL)- 6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J. Clin. Endocrinol. Metab. 82: 1279-1283. PMid:9100607   De Bosscher K, Vanden Berghe W and Haegeman G (2001). Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Mol. Endocrinol. 15: 219-227. PMid:11158329   Eggert M, Schulz M and Neeck G (2001). Molecular mechanisms of glucocorticoid action in rheumatic autoimmune diseases. J. Steroid Biochem. Mol. Biol. 77: 185-191.   Eggert M, Kluter A, Rusch D, Schmidt KL, et al. (2002). Expression analysis of the glucocorticoid receptor and the nuclear factor-kB subunit p50 in lymphocytes from patients with rheumatoid arthritis. J. Rheumatol. 29: 2500-2506. PMid:12465142   Faria CD, Cobra JF, Sousa E Silva, Melo MR, et al. (2008). A very low dose intravenous dexamethasone suppression test as an index of glucocorticoid sensitivity. Horm. Res. 69: 357-362. PMid:18504395   Faria CDC, Castro RB, Longui CA, Kochi C, et al. (2010). Impact of prolonged low-grade physical training on the in vivo glucocorticoid sensitivity and on glucocorticoid receptor mRNA levels of obese adolescents. Horm. Res. Paediatr. 73: 458-464. PMid:20407233   Firestein GS (2004). NF-kappaB: Holy Grail for rheumatoid arthritis? Arthritis Rheum. 50: 2381-2386. PMid:15334448   Fries JF, Spitz PW and Young DY (1982). The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J. Rheumatol. 9: 789-793. PMid:7175852   Fujisawa K, Aono H, Hasunuma T, Yamamoto K, et al. (1996). Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha. Arthritis Rheum. 39: 197-203. PMid:8849369   Ghosh S, May MJ and Kopp EB (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260. PMid:9597130   Longui CA and Faria CD (2009). Evaluation of glucocorticoid sensitivity and its potential clinical applicability. Horm. Res. 71: 305-309. PMid:19506386   Louzada-Junior P, Souza BDB, Toledo RA and Ciconelli RM (2007). Análise descritiva das características demográficas e clínicas de pacientes com artrite reumatóide no estado de São Paulo, Brasil. Rev. Bras. Reumatol. 47: 84-90.   McKay LI and Cidlowski JA (1999). Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 20: 435-459. PMid:10453354